Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
United Therapeutics
Pharma
Sandoz, Liquidia score $137M win in United generic lawsuit
A New Jersey judge ruled that Sandoz is owed damages after a yearslong dispute with United Therapeutics over a generic to the PAH therapy Remodulin.
Zoey Becker
Sep 16, 2024 2:54pm
FDA balks at standard nod to Liquidia's PAH rival to United med
Aug 19, 2024 11:34am
Courts clear FDA to approve Liquidia's PAH drug Yutrepia
Apr 2, 2024 9:33am
FDA approves Johnson & Johnson's combo pill Opsynvi for PAH
Mar 25, 2024 11:05am
FDA faces lawsuit from United on its Liquidia review process
Feb 21, 2024 2:31pm
United Therapeutics lands blow in inhaled drug patent dispute
Sep 1, 2022 12:17pm
